Hospitals; requiring Department of Mental Health and Substance Abuse Services to distribute emergency opioid antagonists to hospitals; requiring hospitals to distribute emergency opioid antagonist to certain persons upon discharge except under certain conditions; granting certain immunities. Effective date.
Impact
The implementation of SB712 represents a significant shift in how hospitals are expected to respond to cases of opioid use issues and aligns with public health goals to mitigate the dangers posed by opioids. By ensuring that patients leave the hospital with emergency opioid antagonists, the bill aims to enhance the chances of survival for individuals at risk of overdose. Furthermore, health benefit plans and the state Medicaid program are required to reimburse hospitals for the distribution of these antagonists, ensuring financial support for healthcare facilities engaging in this public health measure.
Summary
SB712 is a legislative bill aimed at addressing the opioid crisis by requiring hospitals to distribute emergency opioid antagonists, such as naloxone, to patients upon discharge in certain circumstances. The bill mandates that, subject to conditions, hospitals must provide two doses of an emergency opioid antagonist to individuals presenting with an opioid overdose, opioid use disorder, or other adverse effects related to opioid use. This initiative is part of the broader effort to reduce opioid-related fatalities and promote harm reduction strategies. The bill will become effective on November 1, 2023.
Sentiment
Overall, sentiment toward SB712 appears to be supportive, particularly among public health advocates concerned with the opioid epidemic. Proponents argue that the bill will save lives and provide critical resources to individuals at risk. However, there may be concerns regarding the adequacy of funding and resources for hospitals to effectively implement the new requirements. Additionally, discussions may arise about the allocation of emergency opioid antagonists and whether all hospitals will have equal access to these resources, which could impact the effectiveness of the bill in achieving its goals.
Contention
While there is broad support for the core objectives of SB712, discussions around the specifics of implementation, including the distribution process and responsibilities of hospitals, highlighted potential points of contention. Critics may argue that the bill places additional burdens on hospitals without providing sufficient support or guidance. Concerns might also be raised regarding ensuring that all patients, regardless of their insurance status, receive equitable access to emergency opioid antagonists and associated educational resources about opioid use disorder treatment.
Substance abuse services; authorizing the possession, acquisition, distribution and administration of emergency opioid antagonists and adulterant test strips by any person. Effective date. Emergency.
Substance abuse services; making certain school training mandatory; requiring boards of education of public school districts to provide certain personnel with emergency opioid antagonists under specified condition. Effective date. Emergency.
Substance abuse services; making certain school training mandatory; requiring boards of education of public school districts to provide certain personnel with emergency opioid antagonists under specified condition. Effective date. Emergency.
Health: pharmaceuticals; choice of formulation, dosage, and route of administration for opioid antagonists by certain persons and governmental entities if department of health and human services distributes opioid antagonists free of charge; allow. Creates new act.
Permitting the use of expedited partner therapy to treat sexually transmitted infections, authorizing a licensed private psychiatric hospital to maintain a stock supply of emergency medication kits for pharmaceutical emergencies, allowing expired emergency opioid antagonists to be used to treat an opioid overdose, permitting first responders to distribute and administer expired emergency opioid antagonists, permitting a pharmacist to distribute epinephrine delivery systems to a school for use in emergency medication kits and amending definitions related to medication in schools to allow for use of epinephrine delivery systems.